机译:吉法育芽孢杆菌和利福平对健康受试者中塞克利普克药代动力学的影响及其活性代谢物
Department of Clinical PharmacologyActelion Pharmaceuticals LtdAllschwil Switzerland;
Clinical Research Services Kiel GmbHKiel Germany;
Department of Clinical PharmacologyActelion Pharmaceuticals LtdAllschwil Switzerland;
Department of Clinical PharmacologyActelion Pharmaceuticals LtdAllschwil Switzerland;
Clinical Research Services Kiel GmbHKiel Germany;
Department of Clinical PharmacologyActelion Pharmaceuticals LtdAllschwil Switzerland;
CYP2C8; drug interactions; gemfibrozil; pharmacokinetics; rifampicin; selexipag;
机译:吉法育芽孢杆菌和利福平对健康受试者中塞克利普克药代动力学的影响及其活性代谢物
机译:洛匹那韦/利托那韦对健康受试者口服前列环素受体激动剂selexipag药代动力学及其活性代谢产物的影响
机译:洛匹那韦/利托那韦对健康受试者口服前列环素受体激动剂selexipag药代动力学及其活性代谢产物的影响
机译:Amitriptyline HCl的药代动力学及其在正常健康非洲灰鹦鹉(Psittacus Irithacus)和Cockatoos(Cacatua物种)中的代谢物
机译:阿法曲巴帕在健康受试者和慢性肝病患者中的药代动力学/药效学分析
机译:吉非贝齐和利福平对健康受试者沙立哌克及其活性代谢物药代动力学的影响
机译:利福平对Selexipag,口服纤维素受体激动剂的药代动力学的影响及其在健康男性对象中的活性代谢物